Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2003
04/01/2003US6540977 Cyanidin compositions and therapeutic and diagnostic uses therefor
04/01/2003CA2290906C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
04/01/2003CA2101070C Antigen-presenting capsid with fusion ms2-coat protein
03/2003
03/27/2003WO2003025566A2 A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity
03/27/2003WO2003025200A2 Methods of using 22417, a novel human aminoprotease family member
03/27/2003WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor
03/27/2003WO2003025131A2 Protein modification and maintenance molecules
03/27/2003WO2003025129A2 Neurotransmission-associated proteins
03/27/2003WO2003025127A2 Chromogenic in situ hybridization methods, kits, and compositions
03/27/2003WO2003025120A2 Clasp membrane proteins
03/27/2003WO2003025119A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003WO2003025019A1 Anti-pdgf antibodies and methods for producing engineered antibodies
03/27/2003WO2003025012A2 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals
03/27/2003WO2003025009A1 RECOMBINANT ALLERGEN WITH REDUCED IgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
03/27/2003WO2003025003A2 Hiv-gag codon-optimised dna vaccines
03/27/2003WO2003025002A2 Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
03/27/2003WO2003024994A1 Detection and treatment of cancers of the lung
03/27/2003WO2003024993A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
03/27/2003WO2003024940A1 Bifunctional chelating agent for actinium
03/27/2003WO2003024482A1 Crustaceans as production systems for therapeutic proteins
03/27/2003WO2003024481A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
03/27/2003WO2003024480A2 In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
03/27/2003WO2003024442A2 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease
03/27/2003WO2003024404A2 Chemokines as adjuvants of immune response
03/27/2003WO2003024393A2 Autologous t-cell vaccines materials and method
03/27/2003WO2003024392A2 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003WO2003024388A2 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/27/2003WO2003024354A2 Interleukin-12 as a veterinary vaccine adjuvant
03/27/2003WO2003024304A2 Detection and treatment of cancers of the liver
03/27/2003WO2002098889A3 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
03/27/2003WO2002098356A3 Ppp2cs as modifiers of the p53 pathway and methods of use
03/27/2003WO2002092054A3 Immune modulation device for use in animals
03/27/2003WO2002078607A3 Mucin peptide with immunoenhancing properties
03/27/2003WO2002074332A3 Method to enhance the immunogenicity of an antigen
03/27/2003WO2002074237A3 Compositions and methods for the therapy and diagnosis of kidney cancer
03/27/2003WO2002072785A3 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
03/27/2003WO2002064733A3 Protein-protein interactions
03/27/2003WO2002062319A3 Microsphere delivery of mucin peptides
03/27/2003WO2002059291A3 Biological organism for preparing pharmaceutical compositions for treating mammals
03/27/2003WO2002058534A8 Compositions and methods for the therapy and diagnosis of colon cancer
03/27/2003WO2002055100A3 Method and composition for inhibition of tumor growth and enhancing an immune response
03/27/2003WO2002053761A3 Recombinant protective protein from $i(streptococcus pneumoniae)
03/27/2003WO2002048358A3 Regulation of human chemokine-like receptor
03/27/2003WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
03/27/2003WO2002034782A8 Endozepine-like polypeptide nov1 and nucleic acid encoding the same
03/27/2003WO2002034205B1 Using heat shock proteins to increase immune response
03/27/2003WO2002033084A3 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
03/27/2003WO2002029060A3 Hematopoietin receptors hpr1 and hpr2
03/27/2003WO2002026212A3 Microparticle compositions and methods for the manufacture thereof
03/27/2003WO2002020050A9 Eiav p26 deletion vaccine and diagnostic
03/27/2003WO2002018954A9 Inhibition of cmv infection and dissemination
03/27/2003WO2002017962A9 Chemoprotectant for gastric toxicity
03/27/2003WO2002016585A3 Imidazoline receptor homologs
03/27/2003WO2002015932A9 Methods for treating demyelinating diseases
03/27/2003WO2002011667A3 Pharmaceutical compositions and methods useful for modulating angiogenesis
03/27/2003WO2002009750A3 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene
03/27/2003WO2002000692A3 Pd-l2 molecules: pd-1 ligands and uses therefor
03/27/2003WO2001092548A3 Vaccine and gene therapy vector and methods of use thereof
03/27/2003WO2001083794A3 Dna transfection system for the generation of infectious influenza virus
03/27/2003US20030060618 Nucleotide sequences coding polypeptide for use in the treatment of and prevention of lyme disease
03/27/2003US20030060440 Oligodeoxynucleotide and its use to induce an immune response
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030060406 Nucleotide sequence that encodes an amino acid sequence by culturing the host cell for expression of polypeptide; agonist or antagonist
03/27/2003US20030060405 Administering to the subject a composition containing the amino acid sequence hexapeptide
03/27/2003US20030060401 Genetic engineered drug
03/27/2003US20030059922 Sphingosine1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
03/27/2003US20030059896 Nucleotide sequences coding polypeptide for use in the diagnosis and detection of chlamydial infcetions
03/27/2003US20030059895 Protein for use as diagnostic and therapeutic tool in cancer treatment
03/27/2003US20030059894 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of lyme disease
03/27/2003US20030059871 Hematopoietin receptors HPR1 and HPR2
03/27/2003US20030059869 Novel G protein-coupled receptor, GAVE3
03/27/2003US20030059863 N-terminally truncated HER-2/neu protein as a cancer prognostic indicator
03/27/2003US20030059862 Antibodies against tumor necrosis factor delta (APRIL)
03/27/2003US20030059860 Antibody for use in the classification and detection of parasitic infection of mammals
03/27/2003US20030059859 Vertebrate protein for use in human therapeutic and diagnostics
03/27/2003US20030059841 Methods of using bioelastomers
03/27/2003US20030059840 Methods of using bioelastomers
03/27/2003US20030059799 Modified DNA molecule, recombinant containing the same, and uses thereof
03/27/2003US20030059794 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds
03/27/2003US20030059787 Detection of preferential nucleotide sequences coding telomerase; obtain sample containing nucleotide sequences, incubate with probe, detect hybridization product, presence of product indicates gene for telomerase
03/27/2003US20030059773 Immunomodulatory formulations and methods for use thereof
03/27/2003US20030059738 Photosensitivity compound; light source; self-cleaning teeth, mouth
03/27/2003US20030059444 Mucosal vaccine for Neisseria based on native outer membrane vesicles prepared from genetically engineered vaccine strain and unexposed to detergents
03/27/2003US20030059442 Attenuated microorganisms for the treatment of infection
03/27/2003US20030059441 Unmarked mutation is a mutated nucleotide sequence introduced into mycobacterium where sequence does not contain selectable marker such as gene conferring antibiotic resistance to recombinant mycobacterium incorporating mutated sequence
03/27/2003US20030059439 Th1 inducing natural adjuvant for heterologous antigens
03/27/2003US20030059438 Uses for nucleic acid molecules in detecting the presence of pneumococcal surface protein c or of S.pneumoniae by detecting a nucleic acid molecule therefor in a sample such as by amplification and/or a polymerase chain reaction
03/27/2003US20030059437 Invention is based on identification of proteins (including agonist and antagonist antibodies) which either stimulate or inhibit immune response in mammals; immune related diseases can be treated by suppressing or enhancing immune response
03/27/2003US20030059436 Band 3 antigenic peptides, malaria polypeptides and uses thereof
03/27/2003US20030059435 Stable compressed or hard tableted vaccine composition comprising at least one lyophilized antigenic component and a dissolution aid
03/27/2003US20030059434 Administering to the subject an effective amount of a chloride channel modulator
03/27/2003US20030059432 Lipophilin complexes for use in cancer diagnosis and therapy
03/27/2003US20030059431 Prostatic growth factor
03/27/2003US20030059428 Treatment of autoimmune diseases
03/27/2003US20030059426 Method for inducing selectively suppressed immune response to transplanted tissue or cells
03/27/2003US20030059424 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
03/27/2003US20030059423 Method for treating symptoms of diabetes
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030059401 Composition and method for causing photodynamic damage to target cells
03/27/2003US20030059400 Comprises DNA sequence encoding a detectable, cytotoxic protein or protein capable of inducing a detectable signal (luminescent or fluorescent); tumor imaging; gene expression
1 ... 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 ... 1823